8 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
of with Community-Acquired ... Pneumonia (CAP) ... fluoroquinolone #IDSA ... #Community #Acquired ... Management #Guidelines #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Clostridioides Difficile ... Toxic Megacolon, Shock ... post-ABx, but can ... be community-acquired ... Ileus, Megacolon, Shock
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Treating Clostridium difficile ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
Chronic Hepatitis B - Diagnosis and Management Algorithm

• Who to treat: Essentially treat the pts with
CMP. ... HAV immunity; Liver ... Seroconversion is very difficult ... : A Review. ... Diagnosis #Management #Treatment
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
including most CA-MRSA ... choice, both for treatment ... prophylaxis), Community-acquired ... #Pharmacology #Antibiotics ... #Review #Overview
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
exacerbations, community-acquired ... Ceftriaxone for CAP ... Used for MAC treatment ... #Pharmacology #Antibiotics ... #Review #Overview
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
IDSA Recommendations ... Anti-motility agents can ... : • The best treatment ... Microsporidiosis #IDSA ... #HIVAIDS #pharmacology
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... of nonsurgical treatment ... 48–72 h if on treatment ... ) • Patient can ... high risk for C. difficile